Replies to post #706016 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Age for sure. What about comorbidities, treatment histories, tumor region, resection info, and medical history?

you shorts are really dumb as shit
That kind of individual patient data could also never ever be compared between patients in a treatment arm and the control arm.

As I said and will say for the last time the inclusion and exclusion criteria set by NWBO were to mirror a standard nGBM group which the FDA approved.
No two patients are the same. In what you describe it would be IMpossible to conduct medical trials no matter what.
This patient has eaten candy and meat all of his life this patient has a chronic long disorder this patient has a rare DNA deviation this patient is diabetes, this patient has chronic depression, this male patient is 63 years and 8 months etc etc. How for f#c# sake are you going to find 300 placebo patients identical to 300 treatment patients if you morons would write the rules for medical trials?


You shorts really are desperate

[Reefrad]

Why was the data good enough for jama? Your standards are somehow higher? Is your private journal more prestigious?